Ocean Biomedical, Inc.

NASDAQ (USD): Ocean Biomedical, Inc. (OCEA)

Last Price

0.243

Today's Change

0.00 (0.00%)

Day's Change

0.00 - 0.00

Trading Volume

0

Overview

Market Cap

8 Million

Shares Outstanding

34 Million

Avg Volume

257,443

Avg Price (50 Days)

0.63

Avg Price (200 Days)

1.07

PE Ratio

-0.26

EPS

-0.95

Earnings Announcement

26-Feb-2025

Previous Close

0.33

Open

0.57

Day's Range

0.2401 - 0.6594

Year Range

0.2401 - 7.79

Trading Volume

184,415,619

Price Change Highlight

1 Day Change

-26.33%

5 Day Change

-45.00%

1 Month Change

-59.48%

3 Month Change

-72.06%

6 Month Change

-78.86%

Ytd Change

-59.14%

1 Year Change

-58.78%

3 Year Change

-97.57%

5 Year Change

-97.56%

10 Year Change

-97.56%

Max Change

-97.56%

News and Blogs
Latest Hottest Following

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Biotechnology

Description:

Ocean Biomedical, Inc., a biopharmaceutical company, focuses on discovering and developing therapeutic products in oncology, fibrosis, infectious diseases, and inflammation. The company is developing mono-specific and bi-specific humanized monoclonal antibodies (mAb) product candidates targeting Chi3l1 for the treatment of non-small cell lung cancer and glioblastoma multiforme; and a small molecule product candidate targeting Chit1 for the treatment of Idiopathic Pulmonary Fibrosis and Hermansky-Pudlak Syndrome. It is also developing three product candidates based on the WPDS platform, including a malaria vaccine candidate; a humanized mAb malaria therapeutic candidate targeting Plasmodium falciparum glutamic-acid-rich protein (PfGARP); and a small molecule malaria therapeutic candidate targeting PfGARP, as well as a product candidate for the treatment of COVID-19 in hospitalized patients. The company was incorporated in 2019 and is based in Providence, Rhode Island.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment